Received Nov 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HIBV | HIB (ACTHIB) | SANOFI PASTEUR | UNK | UK372AB | OT / RA |
| HPVX | HPV (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | — | OT |
act-hib was accidentally administered instead of intended hpv vaccine with no reported adverse event; Initial information received on 04-Nov-2025 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 12 year old female patient who was accidentally administered HIB (PRP/T) vaccine [ACT-HIB] instead of intended HPV vaccine with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Meningococcal Vaccine A/C/Y/W CONJ (TET TOX) (Menquadfi) for Immunisation. On 03-Nov-2025, the patient received a dose of 0.5ml of suspect HIB (PRP/T) vaccine Powder and solvent for solution for injection (lot UK372AB and expiry date- 31-DEC-2026) via unknown route in the right deltoid for prophylactic vaccination (Immunisation) instead of HPV vaccine (wrong product administered) (latency-same day). Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
MENQUADFI